面向广谱保护:联合呼吸道病毒疫苗的发展和挑战

Yang Wang1,2, Xiaotong Wei1, Yang Liu1,3

  • 1State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.

概括

开发流感,SARS-CoV-2和RSV的联合疫苗对于COVID-19后的呼吸系统健康至关重要. 研究探索各种平台,如mRNA和病毒载体,以有效预防多种病原体.